Free tool
FAERS Monitor: Nicardipine Hydrochloride In 0.9% Sodium Chloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022276 or its brand name (Nicardipine Hydrochloride In 0.9% Sodium Chloride, Nicardipine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
4,421
Serious
4,266
96% of reports
Hospitalization
2,368
Death reported
591
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- acute kidney injury252
- off label use216
- premature baby209
- drug ineffective198
- foetal exposure during pregnancy198
- maternal exposure during pregnancy187
- hypotension175
- drug interaction167
- hypertension167
- pyrexia123
- premature delivery109
- vomiting108
- anaemia107
- diarrhoea106
- hyponatraemia105
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 23 |
| 2005 | 15 |
| 2006 | 108 |
| 2007 | 97 |
| 2008 | 58 |
| 2009 | 77 |
| 2010 | 54 |
| 2011 | 52 |
| 2012 | 126 |
| 2013 | 97 |
| 2014 | 105 |
| 2015 | 140 |
| 2016 | 159 |
| 2017 | 248 |
| 2018 | 358 |
| 2019 | 288 |
| 2020 | 235 |
| 2021 | 313 |
| 2022 | 385 |
| 2023 | 390 |
| 2024 | 410 |
| 2025 | 451 |
| 2026 | 231 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,738 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| premature babySignal | 209 | 33.3 | 29.1 | 6,472 |
| premature deliverySignal | 109 | 32.8 | 27.2 | 3,306 |
| foetal exposure during pregnancySignal | 198 | 11.6 | 10.1 | 1,913 |
| maternal exposure during pregnancySignal | 187 | 10.0 | 8.7 | 1,509 |
| hyponatraemiaSignal | 105 | 8.9 | 7.4 | 727 |
| acute kidney injurySignal | 252 | 7.8 | 7.0 | 1,507 |
| drug interactionSignal | 167 | 5.0 | 4.3 | 536 |
| hypotensionSignal | 175 | 4.2 | 3.6 | 419 |
| hypertensionSignal | 167 | 3.8 | 3.2 | 338 |
| anaemiaSignal | 107 | 2.7 | 2.2 | 111 |
| pyrexia | 123 | 1.7 | 1.4 | 35 |
| off label use | 216 | 1.2 | 1.0 | 6 |
| vomiting | 108 | 1.1 | 0.9 | 1 |
| diarrhoea | 106 | 0.8 | 0.6 | 6 |
| drug ineffective | 198 | 0.7 | 0.6 | 24 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.